Cynosure (CYNO) PT Raised to $62 at Stifel

Go back to Cynosure (CYNO) PT Raised to $62 at Stifel

Brean Capital Raises Price Target as Cynosure (CYNO) Delivers Strong 2Q Results

July 27, 2016 10:58 AM EDT

Brean Capital reiterated a Buy rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $54.00), following the company's 2Q earnings report. Revenue was $110.3 million vs. consensus of $101.3 million. The growth was driven primarily by product expansion in North America. Non-GAAP EPS came in... More

Northland Capital Markets Raises Price Target on Cynosure (CYNO) to $60 Following 2Q

July 27, 2016 10:41 AM EDT

Northland Capital Markets reiterated an Outperform rating on Cynosure (NASDAQ: CYNO), and raised the price target to $60.00 (from $55.00), following the company's 2Q earnings report. CYNO reported revenues of $110M, coming in ahead of the Street's $102M estimates. EPS of $0.27 was also above estimates.... More

Cynosure (CYNO) Tops Q2 EPS by 7c

July 26, 2016 8:09 AM EDT

Cynosure (NASDAQ: CYNO) reported Q2 EPS of $0.36, $0.07 better than the analyst estimate of $0.29. Revenue for the quarter came in at $110.3 million versus the consensus estimate of $101.31 million.

For earnings history and earnings-related data on Cynosure (CYNO) click here.

... More